Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Sep;29(3):1021–1027. doi: 10.1128/iai.29.3.1021-1027.1980

Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.

W P Reed, P Jaffee, E L Albright, R C Williams Jr
PMCID: PMC551233  PMID: 7429626

Abstract

A pneumococcal infection may be lethal in the absence of overwhelming pulmonary involvement, and death may occur even after the organisms have been killed with antibiotics. The mechanism of death is not understood but may be related to circulating pneumococcal products. For investigating the effects of nonviable pneumococci on several host defense mechanisms, rabbits were injected intravenously with 4 X 10(8) colony-forming units of killed sonified type 13 or type 29 pneumococci. Blood was sampled periodically for the next 24 h, and the following were measured: (i) circulating levels of leukocytes; (ii) activity of the classical and alternate complement pathways; and (iii) ability of the serum to opsonize pneumococci for ingestion and killing by polymorphonuclear leukocytes. Saline-injected control rabbits showed no change in any of the functions. Nonimmune rabbits injected with either pneumococcal serotype showed progressive and profound leukopenia, no change or an increase in classical and alternate complement pathway activity, and a profound reduction in the serum-opsonizing capcity for pneumococci of the same serotype as that used in the injection. The opsonizing capacity remained normal for the other serotype. When a previously immunized animal was injected, the opsonizing capacity for the homologous organism remained intact, but leukopenia nervertheless occurred.

Full text

PDF
1021

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTRIAN R., GOLD J. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med. 1964 May;60:759–776. doi: 10.7326/0003-4819-60-5-759. [DOI] [PubMed] [Google Scholar]
  2. Coonrod J. D., Drennan D. P. Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses. Ann Intern Med. 1976 Mar;84(3):254–260. doi: 10.7326/0003-4819-84-3-254. [DOI] [PubMed] [Google Scholar]
  3. Coonrod J. D., Jenkins S. Interaction of pneumococcal antigens with complement in rats. Infect Immun. 1979 Mar;23(3):626–632. doi: 10.1128/iai.23.3.626-632.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coonrod J. D., Rylko-Bauer B. Complement levels in pneumococcal pneumonia. Infect Immun. 1977 Oct;18(1):14–22. doi: 10.1128/iai.18.1.14-22.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Craddock P. R., Fehr J., Brigham K. L., Kronenberg R. S., Jacob H. S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977 Apr 7;296(14):769–774. doi: 10.1056/NEJM197704072961401. [DOI] [PubMed] [Google Scholar]
  6. Dalldorf F. G., Pate D. H., Langdell R. D. Pulmonary capillary thrombosis in experimental pneumococcal septicemia. Arch Pathol. 1968 Feb;85(2):149–161. [PubMed] [Google Scholar]
  7. Dhingra R. K., Williams R. C., Jr, Reed W. P. Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis. Infect Immun. 1977 Jan;15(1):169–174. doi: 10.1128/iai.15.1.169-174.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fine D. P. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun. 1975 Oct;12(4):772–778. doi: 10.1128/iai.12.4.772-778.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Giebink G. S., Verhoef J., Peterson P. K., Quie P. G. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun. 1977 Nov;18(2):291–297. doi: 10.1128/iai.18.2.291-297.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HIRSCH J. G., STRAUSS B. STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM. J Immunol. 1964 Jan;92:145–154. [PubMed] [Google Scholar]
  11. Kronvall G. A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci. J Med Microbiol. 1973 May;6(2):187–190. doi: 10.1099/00222615-6-2-187. [DOI] [PubMed] [Google Scholar]
  12. Nelson R. A., Jr, Biro C. E. Complement components of a haemolytically deficient strain of rabbits. Immunology. 1968 Apr;14(4):527–540. [PMC free article] [PubMed] [Google Scholar]
  13. Perry J. E., Cluff L. E. Clinical and bacteriological events in experimental lethal pneumococcal infection. Tex Rep Biol Med. 1966 Spring;24(1):125–140. [PubMed] [Google Scholar]
  14. Reed W. P., Davidson M. S., Williams R. C., Jr Complement system in pneumococcal infections. Infect Immun. 1976 Apr;13(4):1120–1125. doi: 10.1128/iai.13.4.1120-1125.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stephens C. G., Williams R. C., Jr, Reed W. P. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977 Aug;17(2):296–302. doi: 10.1128/iai.17.2.296-302.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Winkelstein J. A., Shin H. S. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule. J Immunol. 1974 May;112(5):1635–1642. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES